Is it time for geriatricians to get on board with lecanemab? Jason Karlawish and Ken Covinsky
GeriPal
DECEMBER 15, 2022
Along the way we address: Is this degree of slowed cognitive decline meaningful to patients or care partners? Eric: So we’ve had an interesting topic today, storytelling and medicine, narrative medicine… We’ll talk about what we should call it, but before we do, Heather, I think you have a song request.
Let's personalize your content